MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FELSENFELD, H.
Right arrow Articles by HANDSCHUMACHER, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FELSENFELD, H.
Right arrow Articles by HANDSCHUMACHER, R. E.

Molecular Pharmacology, Vol 3, 153-160, Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics

The Interaction between Lysozyme and Penicillin

H. FELSENFELD 1 and R. E. HANDSCHUMACHER 1

1 Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510

The hydrolytic action of lysozyme (muramidase) was inhibited 50% by benzylpenicillin (24 mM) in 0.1 M phosphate buffer at pH 7.0. 7-(Thiophene-2-acetamido)cephalosporin (cephalothin) exerted a similar inhibitory action.

Modification of some of the functional groups of these molecules, with a resultant decrease in their structural similarity to N-acetylmuramic acid, destroyed their inhibitory activity. Integrity of the lactam ring was not essential for activity.

Fluorescence measurements and ultraviolet difference spectroscopy indicated the formation of an enzyme-inhibitor complex. Penicillin and N-acetylglucosamine produced a perturbation peak at 293 mµ when mixed with the enzyme. N-Bromosuccinimide oxidation of the tryptophan residue in position 62, one of six tryptophan units in the enzyme molecule, destroyed enzymatic activity. This modification reduced the size of the perturbation peak induced by penicillin and eliminated the peak caused by N-acetylglucosamine.

The experimental results agree with previous indications that penicillin bears a structural resemblance to a portion of the bacterial cell wall, N-acetylmuramic acid.

In these studies, lysozyme has been used as a model for demonstrating the interaction between penicillin and an enzyme protein. The concentrations of penicillin required for inhibition of lysozyme are far greater than the level of the drug required for the inhibition of sensitive microorganisms.

Note:
ACKNOWLEDGMENTS The authors wish to thank Dr. J. E. Coleman for his constructive suggestions and Dr. Harvey Higgins for supplying the cephalosporin derivatives. This study was supported by a grant from the American Cancer Society (T112 E), and an American Cancer Society Professorship (R.E.H.).

Submitted on October 11, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics